Mesoblast Limited MESO
14.44 USD +0.17 (+1.19%)
At closeNov 9, 2026, 4:00 PM EST
14.44 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
14.06 Day range 14.56
11.95 52-week range 20.96
- YTD
- -19.96%
- 1 year
- -1.16%
News
globenewswire.com Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it hosted a key opinion…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75%…
benzinga.com Why Glaukos Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket Glaukos surged 17.4% premarket after strong Q3 results and raised FY26 sales guidance; INLF, NCPL and PCLA also rallied.
benzinga.com Mesoblast Receives FDA Approval To Implement A New Potency Assay, T-Cell Proliferation Inhibition Bioassay, For Release And Stability Monitoring Of All New Commercial Product Lots Of Its Mesenchymal Stromal Cell Product Ryoncil The TIBA assay will ensure sufficient sensitivity to detect any shifts in potency of the commercial product that could arise during changes in manufacturing processes or production in new facilities.…- benzinga.com Piper Sandler Reiterates Overweight on Mesoblast, Raises Price Target to $39 Piper Sandler analyst Edward Tenthoff reiterates Mesoblast (NASDAQ:MESO) with a Overweight and raises the price target from $35 to $39.
benzinga.com Mesoblast FY EPS $(0.04) Misses $0.01 Estimate, Sales $120.250M Beat $66.000M Estimate Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.01 by 500 percent. This is a 50 percent increase over losses of $(0.09) per…
benzinga.com Full Transcript: Mesoblast FY 2026 Earnings Call Mesoblast (NASDAQ:MESO) released full-year financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive…
benzinga.com Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Moving Lower In Friday’s Pre-Market Session US stock futures rise, Dow up 150 points. Flowers Foods (NYSE:FLO) plunges on poor earnings & lowered forecast. Other stocks also down in pre-market.
benzinga.com Mesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment Mesoblast finished patient dosing in its Phase 3 trial for a cellular back pain treatment, targeting a market worth over $10 billion.
benzinga.com H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers include ANGX, ARGX, and MESO.
benzinga.com Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting worse-than-expected financial results.
benzinga.com PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition proposal, other big gains from Aehr Test, Electrovaya, Robo.ai, Falcon's Beyond, Veradermics, Lucid…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com 8 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fall 13%. Other stocks also down in pre-market.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session 
benzinga.com Alpha Buying: Insider Conviction in High-Risk Biotech 
benzinga.com Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares dip 7.6% in pre-market trading.
benzinga.com Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from the European Patent Office targeting 5-HT4.
benzinga.com Mesoblast H1 EPS $(0.03) Beats $(0.20) Estimate, Sales $51.342M Miss $72.000M Estimate Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.20) by 84.5 percent. This is a 99.26 percent increase over losses of $(4.20)…
benzinga.com Earnings Scheduled For February 26, 2026 
benzinga.com What's Next: Mesoblast's Earnings Preview 
benzinga.com Mesoblast Touts High Survival Rates For FDA-Approved Cell Therapy Mesoblast shares fall after new Ryoncil data show high survival in severe GVHD. Company plans adult trial as analysts keep Hold rating and stock trades near key levels.
benzinga.com Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved Ryoncil, as the company expands hospital access and prepares an adult trial.
benzinga.com FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.
benzinga.com Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales Mesoblast reported strong year‑over‑year growth in December quarter sales of its flagship therapy, Ryoncil.- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
benzinga.com Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket 
benzinga.com This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday 
benzinga.com Reported Sunday, Mesoblast Q1 Revenue Surges To $20.6M As Ryoncil Net Sales Jump 69% Driven By Wider Physician Adoption And Reimbursement Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quarter ended June 30, 2025, and over ten times greater than prior corresponding Q1 FY25.Revenue growth…
benzinga.com Bitfarms, Standard Lithium, Terawulf And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket 
benzinga.com Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket 
benzinga.com Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Mesoblast Shares Are Rising Higher: What's Behind The Move? Mesoblast Limited (NASDAQ:MESO) shares are trading higher on Friday after the company announced that Ryoncil received a J-Code from the United States Medicare & Medicaid Services, streamlining…
benzinga.com White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday 
benzinga.com Nasdaq Down Over 1%; Alibaba Shares Jump Following Q1 Results - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Earnings Scheduled For August 28, 2025 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket 
benzinga.com Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session